Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Non-Current Assets (2017 - 2025)

Historic Non-Current Assets for Inspire Medical Systems (INSP) over the last 9 years, with Q4 2025 value amounting to $323.7 million.

  • Inspire Medical Systems' Non-Current Assets rose 8226.74% to $323.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $933.0 million, marking a year-over-year increase of 4902.0%. This contributed to the annual value of $323.7 million for FY2025, which is 8226.74% up from last year.
  • Per Inspire Medical Systems' latest filing, its Non-Current Assets stood at $323.7 million for Q4 2025, which was up 8226.74% from $221.2 million recorded in Q3 2025.
  • Inspire Medical Systems' 5-year Non-Current Assets high stood at $323.7 million for Q4 2025, and its period low was $12.6 million during Q1 2021.
  • Moreover, its 5-year median value for Non-Current Assets was $64.0 million (2023), whereas its average is $100.8 million.
  • In the last 5 years, Inspire Medical Systems' Non-Current Assets surged by 44080.95% in 2021 and then soared by 353.48% in 2025.
  • Quarter analysis of 5 years shows Inspire Medical Systems' Non-Current Assets stood at $26.5 million in 2021, then soared by 31.25% to $34.8 million in 2022, then skyrocketed by 138.41% to $83.1 million in 2023, then surged by 113.76% to $177.6 million in 2024, then skyrocketed by 82.27% to $323.7 million in 2025.
  • Its Non-Current Assets stands at $323.7 million for Q4 2025, versus $221.2 million for Q3 2025 and $229.0 million for Q2 2025.